COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda.
Saved in:
| Title: | COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda. |
|---|---|
| Authors: | Kusemererwa S; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda. Electronic address: Sylvia.Kusemererwa@mrcuganda.org., Ankunda V; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Ongaria TA; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Abaasa A; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom., Kakande A; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Ssemwanga D; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Kimbugwe G; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Nayiga B; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Bosa HK; Ministry of Health, Kampala, Uganda., Driwale A; Ministry of Health, Kampala, Uganda., Woldemariam YT; World Health Organisation Country Office, Kampala, Uganda., Kisakye A; World Health Organisation Country Office, Kampala, Uganda., Humphreys J; Epiconcept company, Paris 75011, France., Worwui AK; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, Democratic Republic of the Congo., Cohuet S; Epiconcept company, Paris 75011, France., Mwenda JM; The African Region Monitoring Vaccine Effectiveness (AFRO-MoVE) Network, World Health Organisation - Regional Office for Africa, Brazzaville, Democratic Republic of the Congo., Elliott AM; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom., Kaleebu P; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom., Ruzagira E; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom. |
| Source: | Vaccine [Vaccine] 2026 Apr 02; Vol. 77 Suppl 1, pp. 126984. Date of Electronic Publication: 2025 Mar 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
